Canadian Medical Association

CMA activity and submissions

2018

December 4, 2018

CMA response: Health Canada consultation on Canadian drugs and substances strategy

The CMA supports a public health approach to substance use issues, and a comprehensive national strategy to address the harms associated with psychoactive drugs.

January 19, 2018

Proposed Approach to the Regulation of Cannabis

The CMA makes a submission to Health Canada on the proposed cannabis regulations — focusing on prevention, harm reduction, and other measures consistent with a public health approach
2017

December 17, 2017

Excise Duty Framework for Cannabis Products

The CMA weighs in on the federal government’s proposed excise duty framework for cannabis products, highlighting the importance of a public health approach to legalization and recommending tax revenue from cannabis be earmarked to fund prevention, education and treatment initiatives

August 18, 2017

Bill C-45: CMA submission to the House of Commons Standing Committee on Health

The CMA’s submission to the House of Commons Standing Committee on Health recommends the legalization age for cannabis be changed to 21 and that the government undertake a multi-facted public health strategy to minimize the health risks associated with cannabis consumption

August 17, 2017

Bill C-45: CMA submission to the Senate Standing Committee, Social Affairs, Science & Technology

To support deliberations of the House of Commons Standing Committee on Health, the CMA submits a brief on Bill C-45, the Cannabis Act, promoting a broad legal-regulatory framework
2016

August 29, 2016

Legalization, Regulation and Restriction of Access to Marijuana

In a submission to the Government of Canada Task Force on Marijuana Legalization and Regulation, the CMA calls for a broad public health policy approach for cannabis legalization and regulation in Canada
2015

February 28, 2015

CMA Statement Authorizing Marijuana for Medical Purposes

Physicians’ continued concerns about the lack of clinical research, guidance and regulatory oversight for medicinal cannabis prompts CMA to offer members advice on authorizing cannabis for medical purposes and call for unbiased, evidence-based, accredited educational modules and decision-support tools

2014

July 11, 2014

Proposed amendments to the Marijuana for Medical Purposes Regulations

The CMA responds to Health Canada’s proposed regulatory amendments governing medicinal cannabis, raising concerns about the scarcity of evidence for using cannabis as medical therapy as well as other objections to the existing regulatory framework

May 27, 2014

The Health Risks and Harms Associated with the Use of Marijuana

In a submission to the House of Commons Standing Committee on Health, the CMA outlines health risks and harms associated with cannabis use to support the committee’s study on the topic and advocates for a public health approach to psychoactive substance use
2013

February 28, 2013

CMA response: Health Canada’s Medical Marijuana Regulatory Proposal

A CMA submission to Health Canada’s Office of Controlled Substances calls attention to the lack of evidence-based information about the drug’s use as medical therapy and recommends support for scientific research, knowledge translation and other activities to meet physicians’ information needs
2011

December 4, 2011

Medical Marijuana

CMA’s medical marijuana policy recommends further research into the use of cannabis as treatment and calls on the government to develop compulsory education and licensing programs for physicians who authorize the use of cannabis for their patients

Tools & Resources


Tool

Lower-risk cannabis use postcard

Display this postcard in your office or waiting area to so patients can take away reliable information about cannabis use, including recommendations for reducing risk. Derived from the evidence-based recommendations of Canada’s Lower-Risk Cannabis Use Guidelines.

Resource

CMA policy on medical marijuana

Marijuana can offer patients relief when conventional therapies do not — but a lack of evidence of the risks and benefits of its use makes it difficult for physicians to properly advise patients. See the CMA’s recommendations for addressing this issue and others in our policy on medical marijuana.

Tool

Guidelines for lower-risk cannabis use

The CMA supports Canada’s Lower-Risk Cannabis Use Guidelines, a publication of the Centre for Addiction and Mental Health that offers 10 science-based recommendations to help individuals lower the health risks of cannabis use.

Tool

Lower-risk cannabis use poster

Give patients fast facts about cannabis use and ways to reduce risk by displaying this poster in your office or waiting area. The information is based on the recommendations of Canada’s Lower-Risk Cannabis Use Guidelines.

Get Involved

Join the conversation

The CMA provides grants and supports communities of interest to help physicians tackle issues that matter to the medical professions and health care in Canada. 

Have your say

Weigh in on a variety of health policy and professional issues by joining our CMA Member Voice e-Panel. The results of our survey on marijuana informed our August 2016 submission to the federal Task Force on Marijuana Legalization and Regulation. 

Related Resources


Cannabis in Canada fact sheet

This series of fact sheets produced by Health Canada outlines the health impacts of cannabis use, the rules surrounding medical access, as well as the risks of impairment on the road and at work.

Framework for cannabis legalization and regulation in Canada

This final report of Health Canada’s Task Force on Cannabis Legalization and Regulation summarizes the perspectives gathered through consultation and advises on a new system for regulated access to cannabis in Canada.

Cannabis facts and resources

The Canadian Centre on Substance Use and Addiction’s webpage on cannabis has detailed information and resources including a guide on how to talk to youth about cannabis, an interactive map with details about provincial and territorial regulations and more.